{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T19:42:02Z","timestamp":1782243722119,"version":"3.54.5"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01759-6","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T11:26:04Z","timestamp":1745925964000},"page":"3859-3876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development of Novel \u03b1-Amylase Inhibitors: Synthesis, Molecular Docking, and Biochemical Studies"],"prefix":"10.1007","volume":"83","author":[{"given":"K.","family":"Ramakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshma","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenin","family":"Nachimuthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premkumar","family":"Jayaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrakala A","family":"Narasimhulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragney","family":"Deme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Rajagopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akella","family":"Sivaramakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Karthikeyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajagopal","family":"Desikan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"1759_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2174\/1874104501105010068","volume":"5","author":"E Adeghate","year":"2011","unstructured":"Adeghate, E. (2011). Editorial medicinal chemistry of novel anti-diabetic drugs. The Open Medicinal Chemistry Journal, 5, 68\u201369.","journal-title":"The Open Medicinal Chemistry Journal"},{"key":"1759_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2174\/1570163814666170915134018","volume":"15","author":"GL Khatik","year":"2018","unstructured":"Khatik, G. L., Datusalia, A. K., Ahsan, W., Kaur, P., Vyas, M., Mittal, A., & Nayak, S. K. (2018). A Retrospect study on thiazole derivatives as the potential antidiabetic agents in drug discovery and developments. Current Drug Discovery Technologies, 15, 163\u2013177. https:\/\/doi.org\/10.2174\/1570163814666170915134018.","journal-title":"Current Drug Discovery Technologies"},{"key":"1759_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00044-015-1476-8","volume":"25","author":"M Taha","year":"2016","unstructured":"Taha, M., Ismail, N. H., Jamil, W., Imran, S., Rahim, F., Kashif, S. M., & Zulkefeli, M. (2016). Synthesis of 2-(2-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole derivatives and evaluation of their antiglycation potential. Medicinal Chemistry Research, 25, 225\u2013234. https:\/\/doi.org\/10.1007\/s00044-015-1476-8.","journal-title":"Medicinal Chemistry Research"},{"key":"1759_CR4","doi-asserted-by":"publisher","unstructured":"Baynest, H. W. (2015). Classification, pathophysiology, diagnosis and management of diabetes mellitus. Journal of Diabetes and Metabolism, 06. https:\/\/doi.org\/10.4172\/2155-6156.1000541","DOI":"10.4172\/2155-6156.1000541"},{"key":"1759_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.12691\/jaem-2-4-10","volume":"2","author":"A Sundarram","year":"2014","unstructured":"Sundarram, A., & Murthy, T. P. K. (2014). \u03b1-amylase production and applications: A review. Journal of Applied and Environmental Microbiology, 2, 166\u2013175. https:\/\/doi.org\/10.12691\/jaem-2-4-10.","journal-title":"Journal of Applied and Environmental Microbiology"},{"key":"1759_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.18433\/j35s3k","volume":"15","author":"PM Sales","year":"2012","unstructured":"Sales, P. M., Souza, P. M., Simeoni, L. A., & Silveira, D. (2012). \u03b1-Amylase inhibitors: a review of raw material and isolated compounds from plant source. Journal of Pharmacy and Pharmaceutical Sciences, 15, 141\u2013183. https:\/\/doi.org\/10.18433\/j35s3k.","journal-title":"Journal of Pharmacy and Pharmaceutical Sciences"},{"key":"1759_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jep.2016.07.024","volume":"192","author":"B Dai","year":"2016","unstructured":"Dai, B., Wu, Q., Zeng, C., Zhang, J., Cao, L., Xiao, Z., & Yang, M. (2016). The effect of Liuwei Dihuang decoction on PI3K\/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance. Journal of Ethnopharmacology, 192, 382\u2013389. https:\/\/doi.org\/10.1016\/j.jep.2016.07.024.","journal-title":"Journal of Ethnopharmacology"},{"key":"1759_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154887","volume":"126","author":"X Cheng","year":"2024","unstructured":"Cheng, X., Huang, J., Li, H., Zhao, D., Liu, Z., Zhu, L., Zhang, Z., & Peng, W. (2024). Quercetin: A promising therapy for diabetic encephalopathy through inhibition of hippocampal ferroptosis. Phytomedicine, 126, 154887. https:\/\/doi.org\/10.1016\/j.phymed.2023.154887.","journal-title":"Phytomedicine"},{"key":"1759_CR9","doi-asserted-by":"publisher","first-page":"e40412","DOI":"10.1097\/MD.0000000000040412","volume":"103","author":"Y Wei","year":"2024","unstructured":"Wei, Y., Xu, S., Wu, Z., Zhang, M., Bao, M., & He, B. (2024). Exploring the causal relationships between type 2 diabetes and neurological disorders using a Mendelian randomization strategy. Medicine, 103, e40412. https:\/\/doi.org\/10.1097\/MD.0000000000040412.","journal-title":"Medicine"},{"key":"1759_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1422752","volume":"15","author":"K He","year":"2024","unstructured":"He, K., Chen, R., Xu, S., Ding, Y., Wu, Z., Bao, M., He, B., & Li, S. (2024). Environmental endocrine disruptor-induced mitochondrial dysfunction: a potential mechanism underlying diabetes and its complications. Frontiers in Endocrinology, 15, 1422752. https:\/\/doi.org\/10.3389\/fendo.2024.1422752.","journal-title":"Frontiers in Endocrinology"},{"key":"1759_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1416403","volume":"15","author":"W Li","year":"2024","unstructured":"Li, W., Liu, X., Liu, Z., Xing, Q., Liu, R., Wu, Q., Hu, Y., & Zhang, J. (2024). The signaling pathways of selected traditional Chinese medicine prescriptions and their metabolites in the treatment of diabetic cardiomyopathy: a review. Frontiers in Pharmacology, 15, 1416403. https:\/\/doi.org\/10.3389\/fphar.2024.1416403.","journal-title":"Frontiers in Pharmacology"},{"key":"1759_CR12","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.2174\/0113816128302667240422110226","volume":"30","author":"J Liang","year":"2024","unstructured":"Liang, J., He, Y., Huang, C., Ji, F., Zhou, X., & Yin, Y. (2024). The regulation of selenoproteins in diabetes: A new way to treat diabetes. Current Pharmaceutical Design, 30, 1541\u20131547. https:\/\/doi.org\/10.2174\/0113816128302667240422110226.","journal-title":"Current Pharmaceutical Design"},{"key":"1759_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.theochem.2003.08.073","volume":"666\u2013667","author":"L Kandra","year":"2003","unstructured":"Kandra, L. (2003). \u03b1-Amylases of medical and industrial importance. Journal of Molecular Structure: THEOCHEM, 666\u2013667, 487\u2013498. https:\/\/doi.org\/10.1016\/j.theochem.2003.08.073.","journal-title":"Journal of Molecular Structure: THEOCHEM"},{"key":"1759_CR14","first-page":"486","volume":"2","author":"S Das","year":"2011","unstructured":"Das, S., Singh, S., Sharma, V., & Soni, M. L. (2011). Biotechnological applications of industrially important amylase enzyme. International Journal of Pharma and Bio Sciences, 2, 486\u2013496.","journal-title":"International Journal of Pharma and Bio Sciences"},{"key":"1759_CR15","first-page":"799","volume":"59","author":"II Hamdan","year":"2004","unstructured":"Hamdan, I. I., Afifi, F., & Taha, M. O. (2004). In vitro alpha amylase inhibitory effect of some clinically-used drugs. Die Pharmazie, 59, 799\u2013801.","journal-title":"Die Pharmazie"},{"key":"1759_CR16","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1007\/s00044-015-1356-2","volume":"24","author":"S Shahidpour","year":"2015","unstructured":"Shahidpour, S., Panahi, F., Yousefi, R., Nourisefat, M., Nabipoor, M., & Khalafi-Nezhad, A. (2015). Design and synthesis of new antidiabetic \u03b1-glucosidase and \u03b1-amylase inhibitors based on pyrimidine-fused heterocycles. Medicinal Chemistry Research, 24, 3086\u20133096. https:\/\/doi.org\/10.1007\/s00044-015-1356-2.","journal-title":"Medicinal Chemistry Research"},{"key":"1759_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-016-1452-y","volume":"16","author":"MN Wickramaratne","year":"2016","unstructured":"Wickramaratne, M. N., Punchihewa, J. C., & Wickramaratne, D. B. M. (2016). In-vitro alpha amylase inhibitory activity of the leaf extracts of Adenanthera pavonina. BMC Complementary and Alternative Medicine, 16, 466. https:\/\/doi.org\/10.1186\/s12906-016-1452-y.","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"1759_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.phrs.2011.05.009","volume":"64","author":"S Yamagishi","year":"2011","unstructured":"Yamagishi, S., & Matsui, T. (2011). Nitric oxide, a janus-faced therapeutic target for diabetic microangiopathy\u2014Friend or foe? Pharmacological Research, 64, 187\u2013194. https:\/\/doi.org\/10.1016\/j.phrs.2011.05.009.","journal-title":"Pharmacological Research"},{"key":"1759_CR19","first-page":"217","volume":"3","author":"AN Khan","year":"2015","unstructured":"Khan, A. N., Khan, R. A., Ahmad, M., Mushtaq, N., & Khan, A. (2015). Role of antioxidant in oxidative stress and diabetes mellitus. Journal of Pharmacognosy and Phytochemistry, 3, 217\u2013220.","journal-title":"Journal of Pharmacognosy and Phytochemistry"},{"key":"1759_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2337\/diab.40.4.405","volume":"40","author":"JW Baynes","year":"1991","unstructured":"Baynes, J. W. (1991). Role of oxidative stress in development of complications in diabetes. Diabetes, 40, 405\u2013412. https:\/\/doi.org\/10.2337\/diab.40.4.405.","journal-title":"Diabetes"},{"key":"1759_CR21","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1007\/s00044-016-1614-y","volume":"25","author":"T Arshad","year":"2016","unstructured":"Arshad, T., Khan, K. M., Rasool, N., Salar, U., Hussain, S., Tahir, T., & Ismail, N. H. (2016). Syntheses, in vitro evaluation and molecular docking studies of 5-bromo-2-aryl benzimidazoles as \u03b1-glucosidase inhibitors. Medicinal Chemistry Research, 25, 2058\u20132069. https:\/\/doi.org\/10.1007\/s00044-016-1614-y.","journal-title":"Medicinal Chemistry Research"},{"key":"1759_CR22","doi-asserted-by":"publisher","first-page":"103195","DOI":"10.1016\/j.bioorg.2019.103195","volume":"94","author":"R Rafique","year":"2020","unstructured":"Rafique, R., Khan, K. M., Arshia, Kanwal, Chigurupati, S., Wadood, A., & al-Rashida, M. (2020). Synthesis of new indazole based dual inhibitors of \u03b1-glucosidase and \u03b1-amylase enzymes, their in vitro, in silico and kinetics studies. Bioorganic Chemistry, 94, 103195. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103195.","journal-title":"Bioorganic Chemistry"},{"key":"1759_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-17261-w","volume":"7","author":"U Salar","year":"2017","unstructured":"Salar, U., Khan, K. M., Chigurupati, S., Taha, M., Wadood, A., Vijayabalan, S., & Perveen, S. (2017). New hybrid hydrazinyl thiazole substituted chromones: as potential \u03b1-amylase inhibitors and radical (DPPH & ABTS) scavengers. Scientific Reports, 7, 1\u201317. https:\/\/doi.org\/10.1038\/s41598-017-17261-w.","journal-title":"Scientific Reports"},{"key":"1759_CR24","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/MOL.0b013e328339387b","volume":"21","author":"JK Kruit","year":"2010","unstructured":"Kruit, J. K., Brunham, L. R., Verchere, C. B., & Hayden, M. R. (2010). HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitus. Current Opinion in Lipidology, 21, 178\u2013185. https:\/\/doi.org\/10.1097\/MOL.0b013e328339387b.","journal-title":"Current Opinion in Lipidology"},{"key":"1759_CR25","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2337\/diabetes.48.4.783","volume":"48","author":"RS Crawford","year":"1999","unstructured":"Crawford, R. S., Mudaliar, S. R., Henry, R. R., & Chait, A. (1999). Inhibition of LDL oxidation in vitro but not ex vivo by troglitazone. Diabetes, 48, 783\u2013790. https:\/\/doi.org\/10.2337\/diabetes.48.4.783.","journal-title":"Diabetes"},{"key":"1759_CR26","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3390\/molecules22081210","volume":"22","author":"MN Gomes","year":"2017","unstructured":"Gomes, M. N., Muratov, E. N., Pereira, M., Peixoto, J. C., Rosseto, L. P., Cravo, P. V. L., & Neves, B. J. (2017). Chalcone derivatives: Promising starting points for drug design. Molecules, 22, 1210. https:\/\/doi.org\/10.3390\/molecules22081210.","journal-title":"Molecules"},{"key":"1759_CR27","first-page":"223","volume":"36","author":"BE Aks\u00f6z","year":"2011","unstructured":"Aks\u00f6z, B. E., & Ertan, R. (2011). Chemical and structural properties of chalcones I. Fabad J Pharm Sci, 36, 223\u2013242.","journal-title":"Fabad J Pharm Sci"},{"key":"1759_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejmech.2006.09.019","volume":"42","author":"Z Nowakowska","year":"2007","unstructured":"Nowakowska, Z. (2007). A review of anti-infective and anti-inflammatory chalcones. European Journal of Medicinal Chemistry, 42, 125\u2013137. https:\/\/doi.org\/10.1016\/j.ejmech.2006.09.019.","journal-title":"European Journal of Medicinal Chemistry"},{"key":"1759_CR29","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1016\/j.bmcl.2010.05.016","volume":"20","author":"D Kumar","year":"2010","unstructured":"Kumar, D., Kumar, N. M., Akamatsu, K., Kusaka, E., Harada, H., & Ito, T. (2010). Synthesis and biological evaluation of indolyl chalcones as antitumor agents. Bioorganic and Medicinal Chemistry Letters, 20, 3916\u20133919. https:\/\/doi.org\/10.1016\/j.bmcl.2010.05.016.","journal-title":"Bioorganic and Medicinal Chemistry Letters"},{"key":"1759_CR30","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.ejmech.2008.05.010","volume":"44","author":"D Batovska","year":"2009","unstructured":"Batovska, D., Parushev, S., Stamboliyska, B., Tsvetkova, I., Ninova, M., & Najdenski, H. (2009). Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted. European Journal of Medicinal Chemistry, 44, 2211\u20132218. https:\/\/doi.org\/10.1016\/j.ejmech.2008.05.010.","journal-title":"European Journal of Medicinal Chemistry"},{"key":"1759_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0300-483X(02)00578-4","volume":"184","author":"K Monostory","year":"2003","unstructured":"Monostory, K., Tam\u00e1si, V., Vereczkey, L., & Perj\u00e9si, P. (2003). A study on CYP1A inhibitory action of E-2-(4\u2032-methoxybenzylidene)-1-benzosuberone and some related chalcones and cyclic chalcone analogues. Toxicology, 184, 203\u2013210. https:\/\/doi.org\/10.1016\/S0300-483X(02)00578-4.","journal-title":"Toxicology"},{"key":"1759_CR32","doi-asserted-by":"publisher","first-page":"922","DOI":"10.7598\/cst2013.431","volume":"2","author":"CH Sridevi","year":"2013","unstructured":"Sridevi, C. H., Kannan, M., Abhinayani, G., & Sravya, N. (2013). Designing and biological evaluation of new benzimidazole compounds. Chemical Science Transactions, 2, 922\u2013926. https:\/\/doi.org\/10.7598\/cst2013.431.","journal-title":"Chemical Science Transactions"},{"key":"1759_CR33","doi-asserted-by":"publisher","first-page":"5599","DOI":"10.3390\/molecules29235599","volume":"29","author":"PV Rai","year":"2024","unstructured":"Rai, P. V., Ramu, R., Akhileshwari, P., Prabhu, S., Prabhune, N. M., Deepthi, P. V., Anjana, P. T., Ganavi, D., Vijesh, A. M., Goh, K. W., Ahmed, M. Z., & Kumar, V. (2024). Novel benzimidazole-endowed chalcones as \u03b1-glucosidase and \u03b1-amylase inhibitors: An insight into structural and computational studies. Molecules, 29, 5599. https:\/\/doi.org\/10.3390\/molecules29235599.","journal-title":"Molecules"},{"key":"1759_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.bioorg.2018.05.003","volume":"79","author":"A Tajudeen Bale","year":"2018","unstructured":"Tajudeen Bale, A., Mohammed Khan, K., Salar, U., Chigurupati, S., Fasina, T., Ali, F., Kanwal, Wadood, A., Taha, M., Sekhar Nanda, S., Ghufran, M., & Perveen, S. (2018). Chalcones and bis-chalcones: As potential \u03b1-amylase inhibitors; synthesis, in vitro screening, and molecular modelling studies. Bioorganic Chemistry, 79, 179\u2013189. https:\/\/doi.org\/10.1016\/j.bioorg.2018.05.003.","journal-title":"Bioorganic Chemistry"},{"key":"1759_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.131090","volume":"1245","author":"MJ Mphahlele","year":"2021","unstructured":"Mphahlele, M. J., Zamisa, S. J., & El-Gogary, T. M. (2021). Characterization, Hirshfeld surface analysis, DFT study and an in vitro \u03b1-glucosidase\/\u03b1-amylase\/radical scavenging profiling of novel 5-styryl-2-(4-tolylsulfonamido) chalcones. Journal of Molecular Structure, 1245, 131090. https:\/\/doi.org\/10.1016\/j.molstruc.2021.131090.","journal-title":"Journal of Molecular Structure"},{"key":"1759_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/J.MOLSTRUC.2021.129920","volume":"1230","author":"S Chortani","year":"2021","unstructured":"Chortani, S., Horchani, M., Znati, M., Issaoui, N., Jannet, H. B., & Romdhane, A. (2021). Design and synthesis of new benzopyrimidinone derivatives: \u03b1-amylase inhibitory activity, molecular docking and DFT studies. Journal of Molecular Structure, 1230, 129920. https:\/\/doi.org\/10.1016\/J.MOLSTRUC.2021.129920.","journal-title":"Journal of Molecular Structure"},{"key":"1759_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4155\/fmc-2019-008","volume":"12","author":"P Jayaraj","year":"2019","unstructured":"Jayaraj, P., Narasimhulu, C. A., Maiseyeu, A., Durairaj, R., Rao, S., Rajagopalan, S., & Desikan, R. (2019). Methoxyphenol derivatives as reversible inhibitors of myeloperoxidase as potential antiatherosclerotic agents. Future Medicinal Chemistry, 12, 95\u2013110. https:\/\/doi.org\/10.4155\/fmc-2019-008.","journal-title":"Future Medicinal Chemistry"},{"key":"1759_CR38","doi-asserted-by":"publisher","first-page":"7850","DOI":"10.1021\/acsomega.3c07555","volume":"9","author":"R Rajan","year":"2024","unstructured":"Rajan, R., Karthikeyan, S., & Desikan, R. (2024). Synthesis, structural elucidation, in silico and in vitro studies of new class of methylenedioxyphenyl-based amide derivatives as potential myeloperoxidase inhibitors for cardiovascular protection. ACS Omega, 9, 7850\u20137868. https:\/\/doi.org\/10.1021\/acsomega.3c07555.","journal-title":"ACS Omega"},{"key":"1759_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64165-7","volume":"14","author":"L Nachimuthu","year":"2024","unstructured":"Nachimuthu, L., & Desikan, R. (2024). Development of methyl 5-((cinnamoyloxy)methyl)picolinate, exploring its bio-target potential aiming at CVD mediated by multiple proteins through surface and physiochemical analysis. Scientific Reports, 14, 13328. https:\/\/doi.org\/10.1038\/s41598-024-64165-7.","journal-title":"Scientific Reports"},{"key":"1759_CR40","doi-asserted-by":"publisher","first-page":"712","DOI":"10.21577\/1984-6835.20200057","volume":"12","author":"PTD Silva","year":"2020","unstructured":"Silva, P. T. D., Xavier, J. D. C., Teixeira, A. M. R., Santos, H. S., Lopes, L. M. A., Fontenelle, R. O. D. S., & de Paula Cavalcante, T. (2020). Cytotoxic and antifungal activity of chalcones synthesized from natural acetophenone isolated from Croton anisodontus. Revista Virtual De Quimica, 12, 712\u2013723. https:\/\/doi.org\/10.21577\/1984-6835.20200057.","journal-title":"Revista Virtual De Quimica"},{"key":"1759_CR41","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.bmcl.2017.02.038","volume":"27","author":"M Vijaya Bhaskar Reddy","year":"2017","unstructured":"Vijaya Bhaskar Reddy, M., Hung, H.-Y., Kuo, P.-C., Huang, G.-J., Chan, Y.-Y., Huang, S.-C., & Wu, T.-S. (2017). Synthesis and biological evaluation of chalcone, dihydrochalcone, and 1,3-diarylpropane analogs as anti-inflammatory agents. Bioorganic and Medicinal Chemistry Letters, 27, 1547\u20131550. https:\/\/doi.org\/10.1016\/j.bmcl.2017.02.038.","journal-title":"Bioorganic and Medicinal Chemistry Letters"},{"key":"1759_CR42","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.3390\/molecules25112709","volume":"25","author":"MA Dettori","year":"2020","unstructured":"Dettori, M. A., Fabbri, D., Dess\u00ec, A., Dallocchio, R., Carta, P., Honisch, C., & Delogu, G. (2020). Synthesis and studies of the inhibitory effect of hydroxylated phenylpropanoids and biphenols derivatives on tyrosinase and laccase enzymes. Molecules, 25, 2709. https:\/\/doi.org\/10.3390\/molecules25112709.","journal-title":"Molecules"},{"key":"1759_CR43","doi-asserted-by":"publisher","first-page":"923","DOI":"10.2174\/15701808113109990081","volume":"10","author":"P Janaki","year":"2013","unstructured":"Janaki, P., Bhadraiah, B., Nagarjuna, P. A., & Subhashini, N. J. P. (2013). Synthesis and antibacterial activity of novel chalcone derivatives of apocynin. Letters in Drug Design and Discovery, 10, 923\u2013927.","journal-title":"Letters in Drug Design and Discovery"},{"key":"1759_CR44","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/14756366.2021.2018682","volume":"37","author":"XY Deng","year":"2022","unstructured":"Deng, X. Y., Ke, J. J., Zheng, Y. Y., Li, D. L., Zhang, K., Zheng, X., Wu, J. Y., Xiong, Z., Wu, P. P., & Xu, X. T. (2022). Synthesis and bioactivities evaluation of oleanolic acid oxime ester derivatives as \u03b1-glucosidase and \u03b1-amylase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 37, 451\u2013461. https:\/\/doi.org\/10.1080\/14756366.2021.2018682.","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"key":"1759_CR45","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/ijms20020397","volume":"20","author":"YZ Zheng","year":"2019","unstructured":"Zheng, Y. Z., Deng, G., Guo, R., Chen, D. F., & Fu, Z. M. (2019). Substituent effects on the radical scavenging activity of isoflavonoid. International Journal of Molecular Sciences, 20, 397. https:\/\/doi.org\/10.3390\/ijms20020397.","journal-title":"International Journal of Molecular Sciences"},{"key":"1759_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105291","volume":"116","author":"CM Hu","year":"2021","unstructured":"Hu, C. M., Wang, W. J., Ye, Y. N., Kang, Y., Lin, J., Wu, P. P., Li, D. L., Bai, L. P., Xu, X. T., Li, B. Q., & Zhang, K. (2021). Novel cinnamic acid magnolol derivatives as potent \u03b1-glucosidase and \u03b1-amylase inhibitors: Synthesis, in vitro and in silico studies. Bioorganic Chemistry, 116, 105291. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105291.","journal-title":"Bioorganic Chemistry"},{"key":"1759_CR47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s42452-024-05700-z","volume":"6","author":"SJ Mahlo","year":"2024","unstructured":"Mahlo, S. J., More, G. K., Oladipo, A. O., & Lebelo, S. L. (2024). In vitro \u03b1-amylase\/\u03b1-glucosidase, cytotoxicity and radical scavenging potential of Hypoxis hemerocallidea synthesized magnesium oxide nanoparticles. Discover Applied Sciences, 6, 62. https:\/\/doi.org\/10.1007\/s42452-024-05700-z.","journal-title":"Discover Applied Sciences"},{"key":"1759_CR48","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0021-9150(93)90084-8","volume":"102","author":"A Bowie","year":"1993","unstructured":"Bowie, A., Owens, D., Collins, P., Johnson, A., & Tomkin, G. H. (1993). Glycosylated low density lipoprotein is more sensitive to oxidation: Implications for the diabetic patient? Atherosclerosis, 102, 63\u201367. https:\/\/doi.org\/10.1016\/0021-9150(93)90084-8.","journal-title":"Atherosclerosis"},{"key":"1759_CR49","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1464-5491.1991.tb01624.x","volume":"8","author":"TJ Lyons","year":"1991","unstructured":"Lyons, T. J. (1991). Oxidized low density lipoproteins: A role in the pathogenesis of atherosclerosis in diabetes? Diabetic Medicine, 8, 411\u2013419. https:\/\/doi.org\/10.1111\/j.1464-5491.1991.tb01624.x.","journal-title":"Diabetic Medicine"},{"key":"1759_CR50","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1464-5491.1992.tb01783.x","volume":"9","author":"A Ceriello","year":"1992","unstructured":"Ceriello, A., Quatraro, A., & Giugliano, D. (1992). New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabetic Medicine, 9, 297\u2013299. https:\/\/doi.org\/10.1111\/j.1464-5491.1992.tb01783.x.","journal-title":"Diabetic Medicine"},{"key":"1759_CR51","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-3-0348-7460-1_15","volume":"62","author":"H Esterbauer","year":"1992","unstructured":"Esterbauer, H., Waeg, G., Puhl, H., Dieber-Rotheneder, M., & Tatzber, F. (1992). Inhibition of LDL oxidation by antioxidants. EXS, 62, 145\u2013157. https:\/\/doi.org\/10.1007\/978-3-0348-7460-1_15.","journal-title":"EXS"},{"key":"1759_CR52","doi-asserted-by":"publisher","first-page":"6564","DOI":"10.3390\/molecules27196564","volume":"27","author":"S Khan","year":"2022","unstructured":"Khan, S., Iqbal, S., Rahim, F., Shah, M., Hussain, R., Alrbyawi, H., Rehman, W., Dera, A. A., Rasheed, L., Somaily, H. H., Pashameah, R. A., Alzahrani, E., & Farouk, A. E. (2022). New biologically hybrid pharmacophore thiazolidinone-based indole derivatives: synthesis, in vitro \u03b1lpha-amylase and \u03b1lpha-glucosidase along with molecular docking investigations. Molecules, 27, 6564. https:\/\/doi.org\/10.3390\/molecules27196564.","journal-title":"Molecules"},{"key":"1759_CR53","doi-asserted-by":"publisher","first-page":"903","DOI":"10.2174\/1573406416666200611103039","volume":"17","author":"M Ali","year":"2021","unstructured":"Ali, M., Khan, M., Zaman, K., Wadood, A., Iqbal, M., Alam, A., Shah, S., Ashfaq Ur Rehman, Yousaf, M., Rafique, R., & Khan, K. M. (2021). Chalcones: As potent \u03b1-amylase enzyme inhibitors; synthesis, in vitro, and in silico studies. Medicinal Chemistry, 17, 903\u2013912. https:\/\/doi.org\/10.2174\/1573406416666200611103039.","journal-title":"Medicinal Chemistry"},{"key":"1759_CR54","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jconrel.2018.12.014","volume":"294","author":"WR Zhuang","year":"2019","unstructured":"Zhuang, W. R., Wang, Y., Cui, P. F., Xing, L., Lee, J., Kim, D., Jiang, H. L., & Oh, Y. K. (2019). Applications of \u03c0-\u03c0 stacking interactions in the design of drug-delivery systems. Journal of Controlled Release, 294, 311\u2013326. https:\/\/doi.org\/10.1016\/j.jconrel.2018.12.014.","journal-title":"Journal of Controlled Release"},{"key":"1759_CR55","doi-asserted-by":"publisher","first-page":"22508","DOI":"10.1021\/acsomega.3c00702","volume":"8","author":"I Khan","year":"2023","unstructured":"Khan, I., Rehman, W., Rahim, F., Hussain, R., Khan, S., Rasheed, L., Alanazi, M. M., Alanazi, A. S., & Abdellattif, M. H. (2023). Synthesis and in vitro \u03b1-amylase and \u03b1-glucosidase dual inhibitory activities of 1,2,4-triazole-bearing bis-hydrazone derivatives and their molecular docking study. ACS Omega, 8, 22508\u201322522. https:\/\/doi.org\/10.1021\/acsomega.3c00702.","journal-title":"ACS Omega"},{"key":"1759_CR56","doi-asserted-by":"publisher","first-page":"42905","DOI":"10.1021\/acsomega.4c05619","volume":"9","author":"B Kaya","year":"2024","unstructured":"Kaya, B., Acar \u00c7evik, U., \u00c7ift\u00e7i, B., Duran, H. E., T\u00fcrke\u015f, C., I\u015f\u0131k, M., Bostanc\u0131, H. E., Kaplanc\u0131kl\u0131, Z. A., & Beydemir, \u015e. (2024). Synthesis, \u03b1-glucosidase, \u03b1-amylase, and aldol reductase inhibitory activity with molecular docking study of novel imidazo[1,2-a]pyridine derivatives. ACS Omega, 9, 42905\u201342914. https:\/\/doi.org\/10.1021\/acsomega.4c05619.","journal-title":"ACS Omega"},{"key":"1759_CR57","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1021\/acs.biochem.8b00603","volume":"57","author":"AC Carlsson","year":"2018","unstructured":"Carlsson, A. C., Scholfield, M. R., Rowe, R. K., Ford, M. C., Alexander, A. T., Mehl, R. A., & Ho, P. S. (2018). Increasing enzyme stability and activity through hydrogen bond-enhanced halogen bonds. Biochemistry, 57, 4135\u20134147. https:\/\/doi.org\/10.1021\/acs.biochem.8b00603.","journal-title":"Biochemistry"},{"key":"1759_CR58","doi-asserted-by":"publisher","first-page":"28189","DOI":"10.1039\/c8ra03145b","volume":"8","author":"L Jiang","year":"2018","unstructured":"Jiang, L., Zhang, X., Zhou, Y., Chen, Y., Luo, Z., Li, J., Yuan, C., & Huang, M. (2018). Halogen bonding for the design of inhibitors by targeting the S1 pocket of serine proteases. RSC Advances, 8, 28189\u201328197. https:\/\/doi.org\/10.1039\/c8ra03145b.","journal-title":"RSC Advances"},{"key":"1759_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/srep34750","volume":"6","author":"S Jiang","year":"2016","unstructured":"Jiang, S., Zhang, L., Cui, D., Yao, Z., Gao, B., Lin, J., & Wei, D. (2016). The important role of halogen bond in substrate selectivity of enzymatic catalysis. Scientific Reports, 6, 34750. https:\/\/doi.org\/10.1038\/srep34750.","journal-title":"Scientific Reports"},{"key":"1759_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202201134","volume":"20","author":"H Iqbal","year":"2023","unstructured":"Iqbal, H., Akhtar, T., Haroon, M., Akta\u015f, A., Tahir, E., & Ehsan, M. (2023). Synthesis of thiazole-chalcone hybrid molecules: Antioxidant, alpha(\u03b1)-amylase inhibition and docking studies. Chemistry and Biodiversity, 20, e202201134. https:\/\/doi.org\/10.1002\/cbdv.202201134.","journal-title":"Chemistry and Biodiversity"},{"key":"1759_CR61","doi-asserted-by":"publisher","first-page":"20412","DOI":"10.1021\/acsomega.3c00529","volume":"8","author":"A Ali","year":"2023","unstructured":"Ali, A., Shah, M. I. A., Fu, C., Hussain, Z., Qureshi, M. N., Farman, S., Parveen, Z., Zada, A., Nayab, S., Fazil, P., Ateeq, M., Rehman, G., Naeem, M., Ibrahim, M., Khan, M., & Khan, W. (2023). Dihydropyrazole derivatives act as potent \u03b1-amylase inhibitors and free radical scavengers: synthesis, bioactivity evaluation, structure-activity relationship, ADMET, and molecular docking studies. ACS Omega, 8, 20412\u201320422. https:\/\/doi.org\/10.1021\/acsomega.3c00529.","journal-title":"ACS Omega"},{"key":"1759_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104489","volume":"106","author":"F Saleem","year":"2021","unstructured":"Saleem, F., Kanwal, Khan, K. M., Chigurupati, S., Solangi, M., Nemala, A. R., Mushtaq, M., Ul-Haq, Z., Taha, M., & Perveen, S. (2021). Synthesis of azachalcones, their \u03b1-amylase, \u03b1-glucosidase inhibitory activities, kinetics, and molecular docking studies. Bioorganic Chemistry, 106, 104489. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104489.","journal-title":"Bioorganic Chemistry"},{"key":"1759_CR63","doi-asserted-by":"publisher","first-page":"523","DOI":"10.6026\/97320630015523","volume":"15","author":"P Balu","year":"2019","unstructured":"Balu, P., Jas, J. S., & Govindaraj, M. (2019). Design and evaluation of chalconeimine derivatives as \u03b1-amylase inhibitors. Bioinformation, 15, 523\u2013529. https:\/\/doi.org\/10.6026\/97320630015523.","journal-title":"Bioinformation"},{"key":"1759_CR64","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.bioorg.2018.10.010","volume":"82","author":"R Bashary","year":"2019","unstructured":"Bashary, R., & Khatik, G. L. (2019). Design, and facile synthesis of 1,3 diaryl-3-(arylamino)propan-1-one derivatives as the potential alpha-amylase inhibitors and antioxidants. Bioorganic Chemistry, 82, 156\u2013162. https:\/\/doi.org\/10.1016\/j.bioorg.2018.10.010.","journal-title":"Bioorganic Chemistry"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01759-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01759-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01759-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T08:23:05Z","timestamp":1757146985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01759-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":64,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1759"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01759-6","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"8 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}